RASNA THERAPEUTICS INC.

Profile

Company Names

RASNA THERAPEUTICS INC.

Addresses

420 LEXINGTON AVENUE, SUITE 2525, NEW YORK, NY 10170

Phone Numbers

646-396-4087

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

NEVADA

Total Amount Raised:

$2,020,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2016-12-20 
$2,020,000.00 
$10,000,000.00 
$7,980,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BRANCACCIO 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  SYNERGY PHARMACEUTICALS, INC.   |  TROVAGENE INC.   |  ORCHESTRA CALIBER CO-INVESTMENT PARTNERS, LLC   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  SAV ACQUISITION CORP   |  SAV HOLDINGS CORP.   |  TAMIR BIOTECHNOLOGY, INC.   |  CONTRAVIR PHARMACEUTICALS, INC.   |  ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.   |  RASNA THERAPEUTICS INC.   |  TROVAGENE, INC.   |  CARDIFF ONCOLOGY, INC.
RICCARDO 
 
DALLA-FAVERA 
DIRECTOR
CANCER GENETICS INC   |  RASNA THERAPEUTICS INC.
TIZIANO 
 
LAZZARETTI 
EXECUTIVE OFFICER
RASNA THERAPEUTICS INC.
JOHN ALEX 
 
MARTIN 
DIRECTOR
RASNA THERAPEUTICS INC.
JIM 
 
MERVIS 
DIRECTOR
RASNA THERAPEUTICS INC.   |  LUNG THERAPEUTICS, INC.
ALESSANDRO 
 
PADOVA 
DIRECTOR
RASNA THERAPEUTICS INC.
KUNWAR 
 
SHAILUBHAI 
DIRECTOR
SYNERGY PHARMACEUTICALS, INC.   |  SYNERGY PHARMACEUTICALS, INC.   |  RASNA THERAPEUTICS INC.
JAMES 
 
TRIPP 
EXECUTIVE OFFICER, DIRECTOR
RASNA THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-12-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-12-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#